Disease-related cortical thinning in presymptomatic granulin mutation carriers
- PMID: 33418170
- PMCID: PMC7804836
- DOI: 10.1016/j.nicl.2020.102540
Disease-related cortical thinning in presymptomatic granulin mutation carriers
Abstract
Mutations in the granulin gene (GRN) cause familial frontotemporal dementia. Understanding the structural brain changes in presymptomatic GRN carriers would enforce the use of neuroimaging biomarkers for early diagnosis and monitoring. We studied 100 presymptomatic GRN mutation carriers and 94 noncarriers from the Genetic Frontotemporal dementia initiative (GENFI), with MRI structural images. We analyzed 3T MRI structural images using the FreeSurfer pipeline to calculate the whole brain cortical thickness (CTh) for each subject. We also perform a vertex-wise general linear model to assess differences between groups in the relationship between CTh and diverse covariables as gender, age, the estimated years to onset and education. We also explored differences according to TMEM106B genotype, a possible disease modifier. Whole brain CTh did not differ between carriers and noncarriers. Both groups showed age-related cortical thinning. The group-by-age interaction analysis showed that this age-related cortical thinning was significantly greater in GRN carriers in the left superior frontal cortex. TMEM106B did not significantly influence the age-related cortical thinning. Our results validate and expand previous findings suggesting an increased CTh loss associated with age and estimated proximity to symptoms onset in GRN carriers, even before the disease onset.
Keywords: Cortical thickness; Frontotemporal dementia; GRN; Genetic mutations; Presymptomatic.
Copyright © 2020. Published by Elsevier Inc.
Conflict of interest statement
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Figures




References
-
- Adams H.H.H., Verhaaren B.F.J., Vrooman H.A., Uitterlinden A.G., Hofman A., Van Duijn C.M., Van Der Lugt A., Niessen W.J., Vernooij M.W., Ikram M.A. TMEM106B influences volume of left-sided temporal lobe and Interhemispheric structures in the general population. Biol. Psychiatry. 2014;76:503–508. doi: 10.1016/j.biopsych.2014.03.006. - DOI - PubMed
-
- Baker M., Mackenzie I.R., Pickering-Brown S.M., Gass J., Rademakers R., Lindholm C., Snowden J., Adamson J., Sadovnick A.D., Rollinson S., Cannon A., Dwosh E., Neary D., Melquist S., Richardson A., Dickson D., Berger Z., Eriksen J., Robinson T., Zehr C., Dickey C.A., Crook R., McGowan E., Mann D., Boeve B., Feldman H., Hutton M. Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17. Nature. 2006;442:916–919. doi: 10.1038/nature05016. - DOI - PubMed
-
- Beck J., Rohrer J.D., Campbell T., Isaacs A., Morrison K.E., Goodall E.F., Warrington E.K., Stevens J., Revesz T., Holton J., Al-Sarraj S., King A., Scahill R., Warren J.D., Fox N.C., Rossor M.N., Collinge J., Mead S. A distinct clinical, neuropsychological and radiological phenotype is associated with progranulin gene mutations in a large UK series. Brain. 2008;131:706–720. doi: 10.1093/brain/awm320. - DOI - PMC - PubMed
-
- Borroni B., Alberici A., Cercignani M., Premi E., Serra L., Cerini C., Cosseddu M., Pettenati C., Turla M., Archetti S., Gasparotti R., Caltagirone C., Padovani A., Bozzali M. Granulin mutation drives brain damage and reorganization from preclinical to symptomatic FTLD. Neurobiol. Aging. 2012;33:2506–2520. doi: 10.1016/J.NEUROBIOLAGING.2011.10.031. - DOI - PubMed
-
- Borroni B., Alberici A., Premi E., Archetti S., Garibotto V., Agosti C., Gasparotti R., Di Luca M., Perani D., Padovani A. Brain magnetic resonance imaging structural changes in a pedigree of asymptomatic progranulin mutation carriers. Rejuvenation Res. 2008;11:585–595. doi: 10.1089/rej.2007.0623. - DOI - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- 103838/WT_/Wellcome Trust/United Kingdom
- MR/M008525/1/MRC_/Medical Research Council/United Kingdom
- MC_U123160651/MRC_/Medical Research Council/United Kingdom
- MC_UU_00024/1/MRC_/Medical Research Council/United Kingdom
- MC_U105597119/MRC_/Medical Research Council/United Kingdom
- 327387/CIHR/Canada
- MR/J009482/1/MRC_/Medical Research Council/United Kingdom
- MR/K010395/1/MRC_/Medical Research Council/United Kingdom
- WT_/Wellcome Trust/United Kingdom
- MR/T046015/1/MRC_/Medical Research Council/United Kingdom
- MR/M023664/1/MRC_/Medical Research Council/United Kingdom
- BRC149/NS/MH/DH_/Department of Health/United Kingdom
- MR/M018288/1/MRC_/Medical Research Council/United Kingdom
- MC_UU_00005/12/MRC_/Medical Research Council/United Kingdom
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous